Filbrandt Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Filbrandt Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$20K	Buy	341 +13	+4%	+$856	0.01%	114
2021 Q2	$22K	Hold	328	–	–	0.01%	114
2021 Q1	$21K	Sell	328 -733	-69%	-$45.6K	0.01%	113
2020 Q4	$66K	Hold	1,061	–	–	0.04%	71
2020 Q3	$64K	Sell	1,061 -1,068	-50%	-$64.3K	0.05%	72
2020 Q2	$125K	Buy	2,129 +1,068	+101%	+$63.9K	0.1%	56
2020 Q1	$59K	Hold	1,061	–	–	0.07%	60
2019 Q4	$68K	Buy	+1,061	New	+$60.8K	0.06%	66

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Filbrandt Wealth Management's BMY Position: Q3 2021 in Review

Filbrandt Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 4% in Q3 2021, buying an estimated $856 and bringing the position to 341 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #114.

Filbrandt Wealth Management first reported a position in BMY in Q4 2019 and has held it in 8 quarters since. The position peaked at $125K in Q2 2020. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Filbrandt Wealth Management held 341 shares of Bristol-Myers Squibb worth $20K as of Q3 2021.
Filbrandt Wealth Management bought 13 Bristol-Myers Squibb shares in Q3 2021, an estimated $856.
Bristol-Myers Squibb made up 0.01% of Filbrandt Wealth Management's portfolio in Q3 2021, its #114 holding.
Filbrandt Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 8 quarters since.
Filbrandt Wealth Management's Bristol-Myers Squibb position peaked at $125K in Q2 2020.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.